CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
Clinical trials for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: ponatinib trial launches
Disease control Recruiting nowThis study tests the drug ponatinib in children aged 1 to 18 with advanced leukemias, lymphomas, or solid tumors that have come back or not responded to standard treatment. The goal is to find safe doses and see if the drug can shrink tumors or improve blood counts. About 70 chil…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences International Sàrl • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for CML patients: asciminib trial targets treatment failures
Disease control Recruiting nowThis phase 2 study tests asciminib, a daily pill, in 40 adults with chronic myeloid leukemia whose first treatment with a TKI drug didn't work or caused side effects. Participants take asciminib for up to 2 years. The main goal is to see how many achieve a major molecular respons…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC